Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Akkaraju Srinivas
Relationship:  
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   19    
Direct Shares   3,961,226    

Indirect Shares

   37,470,445      
Direct Value   $19,952,606    

Indirect Value

   $413,420,042      
Total Shares   41,431,671      
Total Value   $433,372,648      


Seagen Inc $9,493,396 Paratek Pharmaceuticals Inc $2,635,786 Icagen Inc $0 MEI Pharma Inc $7,808,658 Aravive Inc $1,276 Syros Pharmaceuticals, Inc. $13,490 Seagen Inc $9,493,396 Paratek Pharmaceuticals Inc $2,635,786 Icagen Inc $0 MEI Pharma Inc $7,808,658 Aravive Inc $1,276 Syros Pharmaceuticals, Inc. $13,490
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    5   
    3    

     Stock price went up :
    4   
    1    
     Stock price went down :
    1   
    2    
   
     Gain/Loss Ratio :
   4.0   
   4.0   
     Percentage Gain/Loss :
   28.4%
 -84.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Pharmos Corp PARS Director 0 2006-10-25 2,845,160    Premium*  
            Seagen Inc SGEN Director 2020-05-15 41,503 2008-09-22 600,559    Premium*  
            Paratek Pharmaceuticals Inc PRTK Former 10% Beneficial ... 2011-07-19 1,181,967 0    Premium*  
            World Heart Corp WHRT 10% Owner 2012-08-02 0 2010-01-26 0    Premium*  
            Icagen Inc ICGN 2011-07-28 200,500 0    Premium*  
            Synageva BioPharma Corp GEVA Former Director 0 2012-06-27 1,026,832    Premium*  
            Durata Therapeutics, Inc. DRTX 10% Owner 2012-07-24 0 2012-07-24 3,028,439    Premium*  
            MEI Pharma Inc MEIP 10% Owner 2013-02-19 2,502,775 0    Premium*  
            Zs Pharma, Inc. ZSPH Director 2015-12-17 0 2014-06-23 609,455    Premium*  
            aTyr Pharma Inc LIFE Former 10% Owner, Dire... 2015-05-12 0 2015-05-12 1,866,126    Premium*  
            Aravive Inc ARAV Director 2019-12-02 31,815 2019-12-02 576,066    Premium*  
            Syros Pharmaceuticals, Inc. SYRS Director 2023-12-21 2,666 2023-12-21 1,786,427    Premium*  
            Principia Biopharma Inc PRNB Director 2018-09-18 0 2018-09-18 383,480    Premium*  
            Chinook Therapeutics Inc KDNY Director 2023-08-11 0 2023-08-11 0    Premium*  
            Lenz Therapeutics LENZ 10% Owner 2021-06-29 0 2022-04-12 8,497,067    Premium*  
            Scholar Rock Holding Corp SRRK Director, 10% Owner 0 2023-10-16 6,788,609    Premium*  
            Cargo Therapeutics, Inc. CRGX 10% Owner 0 2023-11-14 4,121,689    Premium*  
            Mineralys Therapeutics, Inc. MLYS 2024-02-12 0 2024-02-12 5,074,916    Premium*  
            Vtv Therapeutics Inc. VTVT 2024-02-27 0 2024-02-27 265,620    Premium*  
* Premium Members only  

Records found :    123         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SYRS Syros Pharmaceuticals, In... Director   –       •      –    2020-06-23 4 AS $11.11 $565,930 I/I (50,953) 1,542,317 0 %
LENZ Lenz Therapeutics 10% Owner   –       –       •   2021-10-13 4 B $13.22 $600,188 I/I 45,400 7,584,766 1.5 %
SYRS Syros Pharmaceuticals, In... Director   –       •      –    2020-06-25 4 AS $11.15 $612,850 I/I (54,972) 1,438,570 0 %
SYRS Syros Pharmaceuticals, In... Director   –       •      –    2017-12-13 4 B $8.97 $613,548 I/I 68,400 803,894 2.1 -
SGEN Seagen Inc Director   –       •      –    2008-09-18 4/A S $12.71 $627,594 I/I (49,378) 617,871 0 -
SGEN Seagen Inc Director   –       •      –    2013-05-10 4 S $37.17 $650,430 D/D (17,500) 10,405 0 -
PRTK Paratek Pharmaceuticals I... Former 10% Beneficial Owner   –       –      –    2011-07-18 4 S $4.49 $729,259 D/D (162,527) 1,264,502 0 -
PRTK Paratek Pharmaceuticals I... 10% Owner   –       –       •   2011-07-13 4 S $5.02 $843,833 D/D (168,235) 1,468,747 0 -
LENZ Lenz Therapeutics 10% Owner   –       –       •   2021-10-06 4 B $13.83 $850,199 I/I 61,475 7,455,345 1.5 %
ARAV Aravive Inc Director   –       •      –    2017-12-01 4 B $2.13 $893,961 I/I 419,700 991,129 2.1 -
LENZ Lenz Therapeutics 10% Owner   –       –       •   2022-01-21 4 B $8.99 $899,000 I/I 100,000 8,011,850 1.5 %
LENZ Lenz Therapeutics 10% Owner   –       –       •   2021-10-08 4 B $13.12 $984,000 I/I 75,000 7,539,366 1.5 %
ARAV Aravive Inc Director   –       •      –    2019-12-02 4 B $7.50 $999,998 I/I 133,333 576,066 2.1 -
SGEN Seagen Inc Director   –       •      –    2008-05-15 4 S $10.14 $1,001,406 I/I (98,758) 842,334 0 -
SGEN Seagen Inc Director   –       •      –    2008-07-29 4 S $10.85 $1,038,215 I/I (95,688) 625,913 0 -
SGEN Seagen Inc Director   –       •      –    2008-09-19 4/A S $12.74 $1,117,247 I/I (87,696) 603,588 0 -
ARAV Aravive Inc Director   –       •      –    2017-12-04 4 B $2.21 $1,135,657 I/I 513,872 1,505,001 2.1 -
ARAV Aravive Inc Director   –       •      –    2018-06-06 4 B $1.74 $1,149,585 I/I 660,681 2,234,732 2.1 -
GEVA Synageva BioPharma Corp Former Director   –       –      –    2012-06-26 4 S $40.16 $1,157,661 I/I (28,827) 1,340,283 0 -
SGEN Seagen Inc Director   –       •      –    2008-05-14 4 S $10.10 $1,225,787 I/I (121,365) 915,496 0 -
MEIP MEI Pharma Inc 10% Owner   –       –       •   2013-02-15 4 S $6.60 $1,301,685 D/D (197,225) 2,802,775 0 -
SGEN Seagen Inc Director   –       •      –    2020-05-05 4 S $167.26 $1,421,710 D/D (8,500) 40,168 0 %
LENZ Lenz Therapeutics 10% Owner   –       –       •   2022-04-12 4 B $4.08 $1,428,000 I/I 350,000 8,459,314 1.5 %
SGEN Seagen Inc Director   –       •      –    2008-07-25 4 S $10.81 $1,601,350 I/I (148,136) 701,432 0 -
SYRS Syros Pharmaceuticals, In... Director   –       •      –    2018-01-31 4 B $9.55 $1,999,999 I/I 209,424 1,059,938 2.1 -
  123  Records found
  1   2   3   4  5      
  Page 4 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us